Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Exonuclease 1

Introduction

Exonuclease 1 is an enzyme that in humans is encoded by the EXO1 gene.[1][2][3]

This gene encodes a protein with 5′ to 3′ exonuclease activity as well as an RNase H activity (endonuclease activity cleaving RNA on DNA/RNA hybrid).[4] It is similar to the Saccharomyces cerevisiae protein Exo1 which interacts with Msh2 and which is involved in DNA mismatch repair and homologous recombination. Alternative splicing of this gene results in three transcript variants encoding two different isoforms.[3]

Meiosis

Meiosis

File:Homologous Recombination.jpg
A current model of meiotic recombination, initiated by a double-strand break or gap, followed by pairing with an homologous chromosome and strand invasion to initiate the recombinational repair process. Repair of the gap can lead to crossover (CO) or non-crossover (NCO) of the flanking regions. CO recombination is thought to occur by the Double Holliday Junction (DHJ) model, illustrated on the right, above. NCO recombinants are thought to occur primarily by the Synthesis Dependent Strand Annealing (SDSA) model, illustrated on the left, above. Most recombination events appear to be the SDSA type.

ExoI is essential for meiotic progression through metaphase I in the budding yeast Saccharomyces cerevisiae and in mouse.[5][6]

Recombination during meiosis is often initiated by a DNA double-strand break (DSB) as illustrated in the accompanying diagram. During recombination, sections of DNA at the 5′ ends of the break are cut away in a process called resection. In the strand invasion step that follows, an overhanging 3′ end of the broken DNA molecule “invades” the DNA of an homologous chromosome that is not broken, forming a displacement loop (D-loop). After strand invasion, the further sequence of events may follow either of two main pathways leading to a crossover (CO) or a non-crossover (NCO) recombinant (see Genetic recombination and Homologous recombination). The pathway leading to a CO involves a double Holliday junction (DHJ) intermediate. Holliday junctions need to be resolved for CO recombination to be completed.

During meiosis in S. cerevisiae, transcription of the Exo1 gene is highly induced.[5] In meiotic cells, Exo1 mutation reduces the processing of DSBs and the frequency of COs.[5] Exo1 has two temporally and biochemically distinct functions in meiotic recombination.[7] First, Exo1 acts as a 5’–3’ nuclease to resect DSB-ends. Later in the recombination process, Exo1 acts to facilitate the resolution of DHJs into COs, independently of its nuclease activities. In resolving DHJs, Exo 1 acts together with MLH1–MLH3 heterodimer (MutL gamma) and Sgs1 (ortholog of Bloom syndrome helicase) to define a joint molecule resolution pathway that produces the majority of crossovers.[8]

Male mice deficient for Exo1 are capable of normal progress through the pachynema stage of meiosis, but most germ cells fail to progress normally to metaphase I due to dynamic loss of chiasmata .[6]

Interactions

Interactions

Exonuclease 1 has been shown to interact with MSH2[2][9][10] and MLH1.[10]

References

References

  1. ↑ Wilson DM III, Carney JP, Coleman MA, Adamson AW, Christensen M, Lamerdin JE (September 1998). “Hex1: a new human Rad2 nuclease family member with homology to yeast exonuclease 1”. Nucleic Acids Res. 26 (16): 3762–8. doi:10.1093/nar/26.16.3762. PMCΒ 147753. PMIDΒ 9685493.
  2. ↑ 2.0 2.1 Schmutte C, Marinescu RC, Sadoff MM, Guerrette S, Overhauser J, Fishel R (November 1998). “Human exonuclease I interacts with the mismatch repair protein hMSH2”. Cancer Res. 58 (20): 4537–42. PMIDΒ 9788596.
  3. ↑ 3.0 3.1 “Entrez Gene: EXO1 exonuclease 1”.
  4. ↑ Qiu J, Qian Y, Chen V, Guan MX, Shen B (June 1999). “Human exonuclease 1 functionally complements its yeast homologues in DNA recombination, RNA primer removal, and mutation avoidance”. J. Biol. Chem. 274 (25): 17893–900. doi:10.1074/jbc.274.25.17893. PMIDΒ 10364235.
  5. ↑ 5.0 5.1 5.2 Tsubouchi H, Ogawa H (2000). “Exo1 roles for repair of DNA double-strand breaks and meiotic crossing over in Saccharomyces cerevisiae”. Mol. Biol. Cell. 11 (7): 2221–33. doi:10.1091/mbc.11.7.2221. PMCΒ 14915. PMIDΒ 10888664.
  6. ↑ 6.0 6.1 Wei K, Clark AB, Wong E, Kane MF, Mazur DJ, Parris T, et al. (2003). “Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility”. Genes Dev. 17 (5): 603–14. doi:10.1101/gad.1060603. PMCΒ 196005. PMIDΒ 12629043.
  7. ↑ Zakharyevich K, Ma Y, Tang S, Hwang PY, Boiteux S, Hunter N (2010). “Temporally and biochemically distinct activities of Exo1 during meiosis: double-strand break resection and resolution of double Holliday junctions”. Mol. Cell. 40 (6): 1001–15. doi:10.1016/j.molcel.2010.11.032. PMCΒ 3061447. PMIDΒ 21172664.
  8. ↑ Zakharyevich K, Tang S, Ma Y, Hunter N (2012). “Delineation of joint molecule resolution pathways in meiosis identifies a crossover-specific resolvase”. Cell. 149 (2): 334–47. doi:10.1016/j.cell.2012.03.023. PMCΒ 3377385. PMIDΒ 22500800.
  9. ↑ Rasmussen, L J; Rasmussen M; Lee B; Rasmussen A K; Wilson D M; Nielsen F C; Bisgaard H C (June 2000). “Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis”. Mutat. Res. NETHERLANDS. 460 (1): 41–52. doi:10.1016/S0921-8777(00)00012-4. ISSNΒ 0027-5107. PMIDΒ 10856833.
  10. ↑ 10.0 10.1 Schmutte, C; Sadoff M M; Shim K S; Acharya S; Fishel R (August 2001). “The interaction of DNA mismatch repair proteins with human exonuclease I”. J. Biol. Chem. United States. 276 (35): 33011–8. doi:10.1074/jbc.M102670200. ISSNΒ 0021-9258. PMIDΒ 11427529.
Further reading

Further reading

  • Liberti SE, Rasmussen LJ (2005). “Is hEXO1 a cancer predisposing gene?”. Mol. Cancer Res. 2 (8): 427–32. PMIDΒ 15328369.
  • Holle GE (1985). “[Pathophysiology of ulcer disease]”. Langenbecks Archiv fΓΌr Chirurgie. 366: 81–7. doi:10.1007/bf01836609. PMIDΒ 2414623.
  • Bonaldo MF, Lennon G, Soares MB (1997). “Normalization and subtraction: two approaches to facilitate gene discovery”. Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMIDΒ 8889548.
  • Tishkoff DX, Amin NS, Viars CS, et al. (1998). “Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination”. Cancer Res. 58 (22): 5027–31. PMIDΒ 9823303.
  • Qiu J, Qian Y, Chen V, et al. (1999). “Human exonuclease 1 functionally complements its yeast homologues in DNA recombination, RNA primer removal, and mutation avoidance”. J. Biol. Chem. 274 (25): 17893–900. doi:10.1074/jbc.274.25.17893. PMIDΒ 10364235.
  • Lee BI, Wilson DM (2000). “The RAD2 domain of human exonuclease 1 exhibits 5′ to 3′ exonuclease and flap structure-specific endonuclease activities”. J. Biol. Chem. 274 (53): 37763–9. doi:10.1074/jbc.274.53.37763. PMIDΒ 10608837.
  • Rasmussen LJ, Rasmussen M, Lee B, et al. (2000). “Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis”. Mutat. Res. 460 (1): 41–52. doi:10.1016/S0921-8777(00)00012-4. PMIDΒ 10856833.
  • Wu Y, Berends MJ, Post JG, et al. (2001). “Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms”. Gastroenterology. 120 (7): 1580–7. doi:10.1053/gast.2001.25117. PMIDΒ 11375940.
  • Schmutte C, Sadoff MM, Shim KS, et al. (2001). “The interaction of DNA mismatch repair proteins with human exonuclease I.”. J. Biol. Chem. 276 (35): 33011–8. doi:10.1074/jbc.M102670200. PMIDΒ 11427529.
  • JΓ€ger AC, Rasmussen M, Bisgaard HC, et al. (2001). “HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLalpha and hMLH1-hEXO1 complexes”. Oncogene. 20 (27): 3590–5. doi:10.1038/sj.onc.1204467. PMIDΒ 11429708.
  • Genschel J, Bazemore LR, Modrich P (2002). “Human exonuclease I is required for 5′ and 3′ mismatch repair”. J. Biol. Chem. 277 (15): 13302–11. doi:10.1074/jbc.M111854200. PMIDΒ 11809771.
  • Lee Bi BI, Nguyen LH, Barsky D, et al. (2002). “Molecular interactions of human Exo1 with DNA”. Nucleic Acids Res. 30 (4): 942–9. doi:10.1093/nar/30.4.942. PMCΒ 100345. PMIDΒ 11842105.
  • Sun X, Zheng L, Shen B (2002). “Functional alterations of human exonuclease 1 mutants identified in atypical hereditary nonpolyposis colorectal cancer syndrome”. Cancer Res. 62 (21): 6026–30. PMIDΒ 12414623.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMCΒ 139241. PMIDΒ 12477932.
  • Jagmohan-Changur S, Poikonen T, Vilkki S, et al. (2003). “EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer”. Cancer Res. 63 (1): 154–8. PMIDΒ 12517792.
  • Sharma S, Sommers JA, Driscoll HC, et al. (2003). “The exonucleolytic and endonucleolytic cleavage activities of human exonuclease 1 are stimulated by an interaction with the carboxyl-terminal region of the Werner syndrome protein”. J. Biol. Chem. 278 (26): 23487–96. doi:10.1074/jbc.M212798200. PMIDΒ 12704184.
  • Alam NA, Gorman P, Jaeger EE, et al. (2004). “Germline deletions of EXO1 do not cause colorectal tumors and lesions which are null for EXO1 do not have microsatellite instability”. Cancer Genet. Cytogenet. 147 (2): 121–7. doi:10.1016/S0165-4608(03)00196-1. PMIDΒ 14623461.
  • Genschel J, Modrich P (2004). “Mechanism of 5′-directed excision in human mismatch repair”. Mol. Cell. 12 (5): 1077–86. doi:10.1016/S1097-2765(03)00428-3. PMIDΒ 14636568.